How can tricyclic sophoridinic derivatives be used as autophagy inhibitors for cancer treatments?

Future Med Chem. 2017 Jun;9(9):835-837. doi: 10.4155/fmc-2017-0081. Epub 2017 Jun 21.

Authors

Yan Xiang Wang¹, Zhan Dong Liu², Chong Wen Bi¹, Lu Liu¹, Hong Bin Deng¹, Dan Qing Song¹

Affiliations

¹ Institute of Medicinal Biotechnology, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100050, China.
² Department of Neurology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.

PMID: 28635310
DOI: 10.4155/fmc-2017-0081

No abstract available

Keywords: anticancer; autophagy; sophoridinic.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents / therapeutic use
Antineoplastic Agents / toxicity*
Autophagy / drug effects*
Humans
Medicine, Chinese Traditional
Neoplasms / drug therapy
Neoplasms / pathology
Nitrogen Mustard Compounds / chemistry
Nitrogen Mustard Compounds / therapeutic use
Nitrogen Mustard Compounds / toxicity

Substances

Antineoplastic Agents
Nitrogen Mustard Compounds
sophoridinic acid